Connection

Evangelos Giamarellos-Bourboulis to Adalimumab

Back to Details
This is a "connection" page, showing publications Evangelos Giamarellos-Bourboulis has written about Adalimumab.
Evangelos Giamarellos-Bourboulis
Connection Strength
1.204
Adalimumab
  1. MABp1 Targeting IL-1a for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study. J Invest Dermatol. 2018 04; 138(4):795-801.
    View in: PubMed
    Score: 0.519
  2. Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies. Wounds. 2017 Nov; 29(11):E98-E102.
    View in: PubMed
    Score: 0.519
  3. Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol. 2021 06; 30 Suppl 1:18-22.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.